Used as a key intermediate in the synthesis of fluorinated pharmaceuticals, particularly in the development of GABA (gamma-aminobutyric acid) analogs. Its trifluoromethyl group enhances metabolic stability and lipid solubility, improving blood-brain barrier penetration in neuroactive drugs. Commonly employed in research for designing enzyme inhibitors and central nervous system agents. Also utilized in the preparation of specialty peptides where fluorination modulates biological activity and pharmacokinetics.